Maltofer 50 mg/ml orale dråber, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

maltofer 50 mg/ml orale dråber, opløsning

vifor france - ferrihydroxid polymaltose komplex - orale dråber, opløsning - 50 mg/ml

Maltofer 100 mg tyggetabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

maltofer 100 mg tyggetabletter

vifor france - ferrihydroxid polymaltose komplex - tyggetabletter - 100 mg

Inpremzia Den Europæiske Union - dansk - EMA (European Medicines Agency)

inpremzia

baxter holding b.v. - insulin human (rdna) - diabetes mellitus - narkotika anvendt i diabetes - inpremzia is indicated for the treatment of diabetes mellitus.

Qutavina Den Europæiske Union - dansk - EMA (European Medicines Agency)

qutavina

eurogenerics holdings b.v. - teriparatid - osteoporose - calciumhomeostase - qutavina is indicated in adults. behandling af osteoporose hos postmenopausale kvinder og hos mænd med øget risiko for brud. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. behandling af osteoporose, der er forbundet med vedvarende systemisk glukokortikoid behandling, kvinder og mænd med øget risiko for fraktur.

Rectogesic 4 mg/g rektalsalve Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

rectogesic 4 mg/g rektalsalve

kyowa kirin holdings b.v. - glyceryltrinitrat - rektalsalve - 4 mg/g

Crysvita Den Europæiske Union - dansk - EMA (European Medicines Agency)

crysvita

kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - narkotika til behandling af knoglesygdomme - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.

Medicinsk oxygen "Nippon Gases Scandinavia" 100 % medicinsk gas, komprimeret Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

medicinsk oxygen "nippon gases scandinavia" 100 % medicinsk gas, komprimeret

nippon gases scandinavia holding as - oxygen - medicinsk gas, komprimeret - 100 %

Medicinsk oxygen "Nippon Gases Scandinavia" 100 % medicinsk gas, kryogen Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

medicinsk oxygen "nippon gases scandinavia" 100 % medicinsk gas, kryogen

nippon gases scandinavia holding as - oxygen - medicinsk gas, kryogen - 100 %

Relaquine 35 mg/ml oral gel Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

relaquine 35 mg/ml oral gel

floris holding bv - acepromazinmaleat - oral gel - 35 mg/ml

Tranquiline 35 mg/ml oral gel Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

tranquiline 35 mg/ml oral gel

floris holding bv - acepromazinmaleat - oral gel - 35 mg/ml